We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 248

Pharmaceutical manufacturer's preemptive suit secures preliminary First Amendment protection for script to promote off-label use
  • Cadwalader Wickersham & Taft LLP
  • USA
  • August 17 2015

On August 7, 2015, the U.S. District Court for the Southern District of New York invoked the First Amendment, granting Amarin Pharma, Inc. (Amarin)


New York district court rejects quality-of-care false certification theory premised on non-compliance with ESRD conditions of coverage
  • Arent Fox LLP
  • USA
  • March 11 2011

In January, the US District Court for the Northern District of New York dismissed a False Claims Act (FCA) case brought by a whistleblower against Dialysis Clinic Inc. (DCI).


Campaign seeks to reinforce Hudson Valley as a biotech industry hub
  • Shook Hardy & Bacon LLP
  • USA
  • November 4 2010

Senator Kirsten Gillibrand (D-N.Y.) and business leaders have reportedly unveiled a “NY BioHud Valley” campaign that highlights the state’s Hudson Valley as a “burgeoning epicenter of the biotech industry.”


Federal judge gives preliminary approval to KPMG settlement in Allou Healthcare class action
  • Orrick, Herrington & Sutcliffe LLP
  • USA
  • September 3 2010

Judge Joanna Seybert of the U.S. District Court for the Eastern District of New York has preliminarily approved a settlement in a securities class action filed by former Allou Healthcare Inc. shareholders alleging fraud by Allou's officers and directors and further alleging that Allou's auditors, which included KPMG LLP and Arthur Andersen LLP, knowingly or recklessly disregarded the falsity of Allou's financial statements.


ICE and Manhattan U.S. Attorney seize multiple internet domains and related assets for online copyright violations in initiative to combat online counterfeiting and piracy
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • July 1 2010

On June 30, 2010, the U.S. Immigration and Customs Enforcement (ICE) and the U.S. Attorney for the Southern District of New York (SDNY) seized nine domain names of websites that engaged in illicit distribution of films; some seizures were within hours of the film’s release in theatres.


$250 million jury verdict in class action sex discrimination case
  • Fenwick & West LLP
  • USA
  • June 9 2010

A federal jury in New York awarded $250 million in punitive damages to a class of female sales representatives on top of more than $3 million in compensatory damages to 12 named plaintiffs in Velez v. Novartis Pharmaceutical Corp.


Punitive damages of $250 million awarded to current and former employees in gender discrimination lawsuit
  • Ogletree Deakins
  • USA
  • May 21 2010

In a case in which over $3 Million in compensatory damages already had been awarded to a group of 12 female former employees claiming gender discrimination, the same jury awarded $250 Million in punitive damages to a class of 5600 female employees and former employees of Novartis Pharmaceutical Corporation for the same claims.


Gene patents no more?
  • Wiley Rein LLP
  • USA
  • March 30 2010

In a 152-page opinion, Judge Robert Sweet of the Southern District of New York has held that Myriad Genetics' patents claiming breast cancer genes and related methods of screening patients for the breast cancer genes are invalid because the inventions are not patentable subject matter.


NY Governor Paterson introduces bill related to interactions between ‘pharmaceutical companies' and health care professionals
  • Epstein Becker Green
  • USA
  • January 29 2010

On January 19, 2010, New York Governor David Paterson introduced Senate Bill 6608 as part of the 2010-11 New York State Executive Budget.


Southern District of New York holds excess insurer liable for reimbursement of foreign defense costs, despite policy’s exclusion of duty to defend
  • Locke Lord LLP
  • USA
  • June 5 2009

Wyeth, a pharmaceutical and health care product manufacturer, purchased 20 of its excess product liability insurance from one insurer in the 1980s.